James Alcorn
Research Subjects
James Alcorn has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Darren E. Stewart
Department of Surgery, NYU Langone Health, New York, New York
3 shared publications - Dimitris Bertsimas
Sloan School of Management, Massachusetts Institute of Technology, Cambridge, USA
3 shared publications - Nikolaos Trichakis
Operations Research Center, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139
3 shared publications - Macey Leigh Levan
Department of Surgery, NYU Grossman School of Medicine, New York, NY, USA
2 shared publications - Rebecca R. Goff
United Network for Organ Sharing, Richmond, Virginia 23219
2 shared publications - Samantha B. Klitenic
Department of Surgery, NYU Langone Health, New York, USA
2 shared publications
Latest Publications
- 22 May 2026
- Published by Springer Nature in Current Transplantation Reports
- Vol. 13 (1) , 21
Beyond Self-Regulation: Moving Toward a Public-Trust Model in Organ Transplant Governance
- 22 May 2026
- Published by Springer Nature in Current Transplantation Reports
- Vol. 13 (1) , 21
Beyond Self-Regulation: Moving Toward a Public-Trust Model in Organ Transplant Governance
- 25 August 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (1) , 192-193
Organ Procurement and Transplantation Network Infrastructure: A High-Value Investment for the Government
- 25 August 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (1) , 192-193
Organ Procurement and Transplantation Network Infrastructure: A High-Value Investment for the Government
- Open Access
- 22 August 2025
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 11 (9) , e1780
Modernizing the Design Process for US Organ Allocation Policy: Toward a Continuous Distribution Policy for Kidneys
Background.: The allocation of a limited supply of donor organs remains a critical challenge for organ transplantation. The analytical tools that policymakers rely upon for improving allocation policy have seen little advancement since the introduction of computer simulation in 1995. In recent years, simulation has increasingly become a bottleneck in the policy design process. Partnering with the Organ Procurement and Transplantation Network Kidney Transplantation Committee, our team introduced new analytical techniques into the policy design process. Methods.: A new simulation algorithm was developed that reduces the time required to simulate 1 y of allocation from >6 h down to about 15 s while using the same simulation model as the preexisting simulator used by the Organ Procurement and Transplantation Network. This improvement enabled the simulation of thousands of allocation policies, allowing the introduction of multiobjective optimization as a primary method for policy design. An interactive website was created for committee members to analyze results and perform policy optimization. Results.: These techniques were applied to the development of new continuous distribution allocation policies for kidneys. We detail the policy design process, present graphical results from 50 000 policy simulations, and highlight 4 policies optimized to balance between multiple objectives differently. Conclusions.: Advances in analytical tools offer a path to improving organ transplantation through more effective and equitable organ allocation policies.
- 22 August 2025
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 11 (9) , e1780
Open AccessModernizing the Design Process for US Organ Allocation Policy: Toward a Continuous Distribution Policy for Kidneys
Background.: The allocation of a limited supply of donor organs remains a critical challenge for organ transplantation. The analytical tools that policymakers rely upon for improving allocation policy have seen little advancement since the introduction of computer simulation in 1995. In recent years, simulation has increasingly become a bottleneck in the policy design process. Partnering with the Organ Procurement and Transplantation Network Kidney Transplantation Committee, our team introduced new analytical techniques into the policy design process. Methods.: A new simulation algorithm was developed that reduces the time required to simulate 1 y of allocation from >6 h down to about 15 s while using the same simulation model as the preexisting simulator used by the Organ Procurement and Transplantation Network. This improvement enabled the simulation of thousands of allocation policies, allowing the introduction of multiobjective optimization as a primary method for policy design. An interactive website was created for committee members to analyze results and perform policy optimization. Results.: These techniques were applied to the development of new continuous distribution allocation policies for kidneys. We detail the policy design process, present graphical results from 50 000 policy simulations, and highlight 4 policies optimized to balance between multiple objectives differently. Conclusions.: Advances in analytical tools offer a path to improving organ transplantation through more effective and equitable organ allocation policies.
- Open Access
- 12 August 2025
- Published by Springer Nature in Current Transplantation Reports
- Vol. 12 (1) , 1-3
Health Services and Resources Administration’s Directive to Halt Continuous Distribution is neither Modern nor Transparent
Purpose of review: This article aims to critically analyze the Health Resources and Services Administration's (HRSA) recent directive to halt the Organ Procurement and Transplantation Network’s (OPTN) continuous distribution initiative, evaluating its implications for modern transplant policy and patient outcomes. Recent findings: Continuous distribution is a data-driven, composite-score based system, developed through extensive collaboration among experts, patients, and ethicists, designed to enhance equity and efficiency in organ allocation. Its early implementation in lung allocation has shown positive impacts on patient outcomes. HRSA’s justification for this directive, citing the need to address allocation out of sequence (AOOS), is challenged as continuous distribution is a powerful tool to address systemic behaviors contributing to AOOS. This unilateral intervention by HRSA staff constitutes an overreach of its oversight role, bypassing the OPTN Board's policy authority and contradicting HRSA’s own public commitments to data-driven decision-making. Summary: HRSA’s directive undermines the foundational legal structure of the National Organ Transplantation Act, wastes community-driven progress, and directly threatens fair access to life-saving organs. This commentary urges HRSA to reverse its directive, honor the OPTN Board’s authority, and ensure that scientific evidence, not political influence, guides the future of organ allocation in the United States.
- 12 August 2025
- Published by Springer Nature in Current Transplantation Reports
- Vol. 12 (1) , 1-3
Open AccessHealth Services and Resources Administration’s Directive to Halt Continuous Distribution is neither Modern nor Transparent
Purpose of review: This article aims to critically analyze the Health Resources and Services Administration's (HRSA) recent directive to halt the Organ Procurement and Transplantation Network’s (OPTN) continuous distribution initiative, evaluating its implications for modern transplant policy and patient outcomes. Recent findings: Continuous distribution is a data-driven, composite-score based system, developed through extensive collaboration among experts, patients, and ethicists, designed to enhance equity and efficiency in organ allocation. Its early implementation in lung allocation has shown positive impacts on patient outcomes. HRSA’s justification for this directive, citing the need to address allocation out of sequence (AOOS), is challenged as continuous distribution is a powerful tool to address systemic behaviors contributing to AOOS. This unilateral intervention by HRSA staff constitutes an overreach of its oversight role, bypassing the OPTN Board's policy authority and contradicting HRSA’s own public commitments to data-driven decision-making. Summary: HRSA’s directive undermines the foundational legal structure of the National Organ Transplantation Act, wastes community-driven progress, and directly threatens fair access to life-saving organs. This commentary urges HRSA to reverse its directive, honor the OPTN Board’s authority, and ensure that scientific evidence, not political influence, guides the future of organ allocation in the United States.
- 1 July 2024
- Published by Institute for Operations Research and the Management Sciences (INFORMS) in Operations Research
- Vol. 72 (4) , 1475-1486
Reshaping National Organ Allocation Policy
Working with U.S. policymakers to redesign national organ allocation The Organ Procurement & Transplantation Network (OPTN), which manages transplantation activities in the United States, recently partnered with the MIT Operations Research Center to design and implement novel organ allocation policies that are more equitable, efficient, and inclusive. National organ allocation policies need to strike a delicate balance between efficiency and fairness in multiple objectives, reconciling often disparate value judgments and priorities from many different stakeholders. In “Reshaping National Organ Allocation Policy,” T. Papalexopoulos, J. Alcorn, and D. Bertsimas et al. introduced a novel optimization- and machine learning-based framework to aid policy design and navigate challenging fairness-efficiency tradeoffs. The authors collaborated with the OPTN to apply the framework to the design of a new national allocation policy for lungs, which was implemented in March 2023 and is anticipated to reduce waitlist mortality by approximately 20%. Based on this success, the authors are now working toward the redesign of the entire U.S. organ allocation system, including kidneys, pancreata, hearts, and livers.
- 1 July 2024
- Published by Institute for Operations Research and the Management Sciences (INFORMS) in Operations Research
- Vol. 72 (4) , 1475-1486
Reshaping National Organ Allocation Policy
Working with U.S. policymakers to redesign national organ allocation The Organ Procurement & Transplantation Network (OPTN), which manages transplantation activities in the United States, recently partnered with the MIT Operations Research Center to design and implement novel organ allocation policies that are more equitable, efficient, and inclusive. National organ allocation policies need to strike a delicate balance between efficiency and fairness in multiple objectives, reconciling often disparate value judgments and priorities from many different stakeholders. In “Reshaping National Organ Allocation Policy,” T. Papalexopoulos, J. Alcorn, and D. Bertsimas et al. introduced a novel optimization- and machine learning-based framework to aid policy design and navigate challenging fairness-efficiency tradeoffs. The authors collaborated with the OPTN to apply the framework to the design of a new national allocation policy for lungs, which was implemented in March 2023 and is anticipated to reduce waitlist mortality by approximately 20%. Based on this success, the authors are now working toward the redesign of the entire U.S. organ allocation system, including kidneys, pancreata, hearts, and livers.
- 23 January 2024
- Published by Springer Nature in Current Transplantation Reports
- Vol. 11 (1) , 7-14
Continuously Balancing the Ethics of Organ Allocation
- 23 January 2024
- Published by Springer Nature in Current Transplantation Reports
- Vol. 11 (1) , 7-14
Continuously Balancing the Ethics of Organ Allocation
- 1 September 2023
- Published by Institute for Operations Research and the Management Sciences (INFORMS) in INFORMS Journal on Applied Analytics
- Vol. 53 (5) , 350-358
Applying Analytics to Design Lung Transplant Allocation Policy
- 1 September 2023
- Published by Institute for Operations Research and the Management Sciences (INFORMS) in INFORMS Journal on Applied Analytics
- Vol. 53 (5) , 350-358
Applying Analytics to Design Lung Transplant Allocation Policy
- Open Access
- 17 August 2022
- Published by Elsevier in American Journal of Transplantation
- Vol. 22 (12) , 3093-3100
ABO-adjusted calculated panel reactive antibody (cPRA): A unified metric for immunologic compatibility in kidney transplantation
- 17 August 2022
- Published by Elsevier in American Journal of Transplantation
- Vol. 22 (12) , 3093-3100
Open AccessABO-adjusted calculated panel reactive antibody (cPRA): A unified metric for immunologic compatibility in kidney transplantation